It is an immune- mediated inflammatory disorder.

It damages the inner layer of the rectum or colon.

It causes inflammation and ulcers.

Early symptoms of ulcerative colitis-

Symptoms may come and go, followed by flare-ups.

• Frequent watery stools
• Blood in the stool
• Mucus in the stool
• Persistent abdominal pain and cramps
• Strong sudden urge to defecate
• Weakness or tiredness
• Increased bowel frequency

Ulcerative colitis needs early management:

Symptoms for ulcerative colitis may be infrequent.

The inflammation continues to progress.

The risk of complications still exists.

Can ulcerative colitis be cured?

Ulcerative colitis does not have a specific medications.

The complications or symptoms can be managed.

Long-term management of ulcerative colitis-

The treatment approach aims to –

• Reduce inflammation
• Protect the gastrointestinal lining
• Prevent flare-ups

Common medicines include:

5-aminosalicylic acid (5-ASA) medicines:

They include mesalamine, olsalazine, and sulfasalazine.

They reduce inflammation.

They may be used for a long duration.

They help manage mild to moderate condition.

Corticosteroids:

These are used to provide short-term relief.

They suppress the immune system.

They are used to manage acute flare-ups.

Immunomodulators:

• Azathioprine
• Mercaptopurine

These medicines may be used for long durations in selected people.

Biologics and small-molecule drugs:

These target specific pathways.

These are used in moderate to severe colitis.

They reduce the inflammatory and immune responses.

Commonly used medicine in ulcerative colitis:

Mesalamine is generally a well-tolerated 5-ASA derivative.

Mesalamine, available as Mesalzer, is manufactured by Aprazer Healthcare.

As a gastroenterology medicine manufacturer, we aim to manufacture affordable medicines without compromising quality.

We have a strong distribution network spanning Asian, African, and American countries.

Our portfolio comprises GIT-targeted drugs like:

• Antibiotics for gastrointestinal infections
• Ulcerative colitis medicines
• Acid-relieving medicines

Why must I not stop medicines even if my symptoms subside?

Medicines must be stopped only after a doctor’s advice.

Symptoms may subside, but the condition may still prevail.

How does it cause blood in the stool?

The inflammation and open sores may induce bleeding.

Conclusion:

Ulcerative colitis requires long-term management.

The complications can be managed for long-term remission.

Organ transplant recipients may need lifelong medication.

However, the doses or treatment plan may evolve depending on the patient’s health.

The Role of Anti-rejection Medicines after a Transplant:

The immune system of the body views the new organ as a foreign object.

This may increase the risk of rejection of the graft.

The anti-rejection medicines are given to suppress the immune attack on the new graft.

Intensive drug therapy may be needed initially to prevent the risk of rejection after the surgery.

Later, the treatment may be followed by oral medication for long-term maintenance.

 Medicines used in organ transplantation-

Calcineurin inhibitors-

These reduce the activation of T-cells and lower the immune response.

These are commonly used in heart, kidney, and liver transplants.

Examples of drugs include:

• Tacrolimus
• Cyclosporine

Corticosteroids-

These reduce inflammation and also suppress the immune response.

Examples include:

• Prednisone and prednisolone
• Methylprednisolone

Antimetabolites-

These work by interfering with immune cell activation pathways.

These are commonly given in combination with calcineurin inhibitors or corticosteroids.

The common drugs include:

• Mycophenolate mofetil
• Azathioprine

mTOR Inhibitors-

They interfere with cell growth and proliferation.

These inhibit mTOR signaling.

They prevent immune cell replication.

Common examples include:

• Sirolimus
• Everolimus

Other medicines that may be used after organ transplant include:

• Antivirals
• Antibiotics
• Blood pressure medicines
• Gastrointestinal medicines

At Aprazer Healthcare, we aim to manufacture affordable immunosuppressants to reduce the financial burden of expensive transplant treatment.

We are a nephrology medicine manufacturer.

We manufacture a range of targeted medicines for kidney disorders, including kidney transplant medicines.

Our portfolio includes a comprehensive range of general and specialty medicines.

We are one of the recognized exporters of nephrology medicines.

Difference between acute organ rejection and chronic organ rejection –

Acute organ rejection is a sudden, aggressive immune response to the graft.

An acute attack may be treatable and needs immediate treatment.

Chronic rejection is a gradual process.

The graft may get damaged progressively over the years.

It may be asymptomatic at initial stages.

Can I miss or change immunosuppressive drug regimen on my own?

Patients must not change or stop the medicine on their own.

If the dose is reduced or missed, it may increase the risk of organ rejection.

Excessive doses of immunosuppressants may increase the risk of infection and drug toxicity.

Patients must inform the doctor about all the medicines or OTC drugs they are using.

Parameters that must be regularly monitored –

Certain rejection episodes may cause mild or no symptoms.

This necessitates regular monitoring of organ functions and drug levels.

The common functions to be assessed include:

• Kidney function
• Liver function
• Blood counts
• Drug-level monitoring
• Cardiovascular functions
• Metabolic health

Common symptoms that may occur due to graft rejection:

• Fever
• Extreme weakness
• Pain and tenderness in the region of the graft
• Fluid retention or swelling
• Organ-specific dysfunction

Oral chemotherapy includes capsules, tablets, or liquids taken by mouth.

IV chemotherapy is the delivery of drugs through the intravenous route.

The choice between oral and IV administration is evaluated by the doctor based on the type/spread of cancer and the patient’s condition.

When is chemotherapy given orally?

The oral treatment may be given as primary treatment or used for long–term maintenance therapy.

Certain oral chemotherapy drugs may be used alongside radiation therapy as required for the treatment.

Many targeted cancer drugs are available in oral formulations.

When is chemotherapy given intravenously?

Some of the chemotherapy medicines are not available in oral forms.

IV chemotherapy may be used to treat advanced or metastatic cancer.

The drugs are added directly into the bloodstream.

This helps circulate the drug throughout the body.

IV infusion may be used when controlled, slow administration of the chemotherapy is required.

It may be used when oral therapy may not be available or suitable.

Common examples of oral chemotherapy medicines –

• Capecitabine
• Cyclophosphamide
• Temozolomide
• Etoposide

Common examples of IV chemotherapy drugs include:

• Cisplatin
• Carboplatin
• Paclitaxel
• Docetaxel
• Doxorubicin

As a generic drug manufacturer, Aprazer Healthcare manufactures a range of affordable anticancer medicines.

Our portfolio comprises oral anticancer drugs and chemotherapy injections.

The top- selling anticancer drugs manufactured by Aprazer Healthcare include:

• Etoposide 100mg/5ml injection – Posiact
• Capecitabine 500mg tablets – Capekast
• Carboplatin injection available in two strengths –

Carboplatin 150mg/45ml – Carbokast-150

Carboplatin 450mg/45ml – Carbokast 450

Are the side effects caused by oral or IV chemotherapy different?

The chemotherapy aims to kill cancer cells or inhibit cancer growth.

The different anticancer drugs have distinct mechanisms of action.

The drugs administered through different routes may show similar side-effects.

However, the severity of the side effects may vary depending upon several factors like dosage, patient’s condition.

The oral medicines may not be suitable for people having issues with swallowing.

Certain cytotoxic drugs may irritate the vein when administered intravenously.

The common side effects include:

• Nausea
• Vomiting
• Fatigue
• Hair loss
• Reduced blood count
• Mouth sores

Rheumatoid arthritis is an autoimmune condition.

The immune system attacks the joint lining.

It causes inflammation, causing damage to the joint.

It involves the joints of the hands, wrists, and feet.

The risk factors for developing rheumatoid arthritis-

Non–modifiable factors include-

• Age and sex – Women are more likely to develop arthritis compared to men.

The rheumatoid arthritis can affect people at any age, but the risk increases with the rising age.

• Family history and genetics –

If the disease runs in the family, it increases the risk of the person developing the disease.

Lifestyle risk factors include-

• Smoking – Tobacco smoking may increase the risk in people with genetic predisposition or worsen the symptoms.
• Obesity – Excessive weight is linked to an increased risk of inflammation and disease severity.
• Environmental pollutants – Long-term exposure to pollutants or toxins may increase the risk of developing RA.

The treatment plan for rheumatoid arthritis-

The treatment plan focuses on controlling joint inflammation and preventing further damage.

Key medicines include-

• Conventional DMARDs
• Biological DMARDs
• Targeted synthetic DMARDs
• NSAIDs and corticosteroids for symptomatic relief

At Aprazer Healthcare, we manufacture a range of rheumatology medicines.

As a rheumatology medicine manufacturer and exporter, we export drugs worldwide.

Why might I need to change the treatment plan?

The doctor must evaluate the patient’s condition and the drug response.

According to the condition, medicine may be added, or the dose may be adjusted.

The doctor must regularly assess disease activity, monitoring symptoms and side effects.

One must not stop medication on one’s own, even if one does not experience the symptoms.

Medication must not be stopped or changed without consulting the doctor.

The factors that are evaluated to change the medicine:

1. Persistent and intolerable side effects.
2. Underlying health changes
3. Pregnancy
4. Drug interactions
5. Disease flare-ups

The common types and classifications of rheumatoid arthritis-

Seropositive Rheumatoid Arthritis-

It is a condition in which blood tests show a detection of RF, anti-citrullinated protein antibodies (ACPA), or both.

Seronegative Rheumatoid Arthritis-

The patients experience arthritis symptoms and show negative results for RF and anti-citrullinated protein antibodies (ACPA).

Juvenile idiopathic arthritis (JIA)-

It is an arthritis condition developed in childhood (below 16 years of age).

It must not be misunderstood as a young form of adult rheumatoid arthritis.

Elderly-Onset Rheumatoid Arthritis-

It is a chronic condition that occurs in older people.

Why trust rheumatology medicines manufacturer from Aprazer Healthcare?

Aprazer Healthcare is a pharmaceutical manufacturer specializing in rheumatology medicines.

We are a GMP-certified manufacturer.

We export medicines to countries in Asia, Africa, and the Americas.

Our product portfolio consists of:

• HQKAST 200 (Hydroxychloroquine Sulphate)
• Tofamark (Tofacitinib)

The patients in the ICU are at increased risk of acquiring infections due to severe illness, indwelling devices, and invasive procedures.

Antibiotics are widely used to treat severe infections like ventilator-associated pneumonia, sepsis, etc.

They are generally given through the intravenous route for prompt control.

The IV route offers 100% bioavailability.

The drug directly enters the bloodstream.

The commonly used antibiotics include:

Carbapenems:

These are broad-spectrum antibiotics, bactericidal in nature.

Common uses include:

• Complicated intra-abdominal infections
• Multidrug-resistant bacterial infections
• Hospital-acquired pneumonia
• Complicated urinary tract infection

Beta-lactam/beta-lactamase inhibitors –

Beta-lactam antibiotics are combined with beta-lactamase inhibitors.

Bacteria produce the beta-lactamase enzyme to break down the antibiotic structure.

Beta-lactamase inhibitors inhibit this enzyme.

The inhibitors help preserve the antibiotic structure and prevent its inactivation.

These are used to treat:

• Respiratory infections
• Urinary-tract infections
• Intra-abdominal infections
• Skin-soft tissue infection

Cephalosporins –

This is a class of beta-lactam antibiotics.

These are classified into 5 generations with different antibacterial activity.

These are widely used to treat –

• Pneumonia
• Skin /soft tissue infections
• Meningitis
• Bone or joint infections
• Urinary tract infections

 Glycopeptides –

These may be used as an alternative in certain people with penicillin/cephalosporin allergies.

These may be used for specific Gram-positive bacterial infections, including:

• MRSA- methicillin-resistant Staphylococcus aureus infection
• Bone/joint infections
• Pneumonia caused by susceptible Gram-positive bacteria
• Sepsis caused by susceptible Gram-positive bacteria
• Vancomycin is used in selected cases of C. difficile infection

Aminoglycosides –

These are potent antibiotics, bactericidal in nature.

They are effective against many aerobic and Gram-negative bacteria.

They may be used in selective cases:

• Sepsis
• UTI
• Certain hospital-acquired infections
• Bacterial Endocarditis

Which is the critical care medicine manufacturer in India?

Aprazer Healthcare is a pharmaceutical manufacturer and exporter.

We manufacture a wide range of antibiotic combinations.

As a critical care medicine manufacturer, we are a global exporter of antibiotics.

Our manufacturing units are GMP-certified and equipped with modern infrastructure.

Our flagship products for ICU care include:

• Aptriax-S – Ceftriaxone and Sulbactam
• Piperaxis-4.5 gm – Piperacillin and Tazobactam

Conclusion:

The drug choice and the dose are decided by the doctor after evaluating the patient’s condition, severity of infection, susceptibility, and conformity of the causative agent.

Antibiotic stewardship is important –

Antibiotic therapy must be reviewed based on culture and susceptibility results in order to minimize antimicrobial drug resistance.

Erectile dysfunction is rapidly rising among both young people and adults.

The factors that may contribute to ED:

Poor blood circulation:

Certain medical conditions may interrupt or reduce blood flow and damage blood vessels.

The reduced blood flow to the penis may impair erection.

It may include conditions like:

• Atherosclerosis
• High blood pressure and cholesterol

Metabolic conditions –

Certain chronic disorders like diabetes and obesity may impair blood vessels.

Nerve damage or surgical issues-

• Neurological issues-

Many health conditions like multiple sclerosis or parkinson’s may damage the nerves.

This interrupts the nerve-brain connection.

It may interfere with brain signaling to develop or maintain an erection.

• Spinal cord injury: It may disrupt the signaling pathways for erection.
• Prostate or bladder surgeries:

Pelvic surgeries may cause injury to nearby blood vessels or nerves.

• Peyronie’s Disease: It is an inelastic tissue buildup in the penis.

It causes a bend or curvature in the penis.

It may lead to painful erections or ED in certain individuals.

Medication and substance abuse –

Certain prescription medicines may interrupt erectile function.

These may reduce blood flow, hormones, or affect the CNS.

These include certain –

• antipsychotic drugs
• hormonal medicines
• antihistamines
• blood pressure medicines

Smoking may narrow the blood vessels of the penis.

Excessive alcohol may alter hormone balance and may contribute to ED.

Psychological factors-

Stress or mental conditions may lower libido and affect erection.

 Hormonal changes:

Disruption in hormones, impaired thyroid secretion, may add up to erectile dysfunction.

Is erectile dysfunction treatable?

It can be improved by managing underlying conditions.

Erectile dysfunction can be managed with appropriate medication.

The medicines used in ED-

Phosphodiesterase type 5 (PDE5) inhibitors are the commonly used drugs in ED.

These drugs relax the penile muscle and increase the blood flow to the penis, which helps with erections.

Sildenafil – It is usually taken on an empty stomach about an hour before intercourse.

Its effect may last for 4 hours.

Tadalafil- It is taken 30 minutes before sexual activity.

It may be effective for 36 hours.

The affordable brands for erectile dysfunction medicines-

Viabest-100(sildenafil) and Tadabest-20 (tadalafil), manufactured by Aprazer Healthcare.

Aprazer Healthcare is an erectile dysfunction medicine manufacturer.

We manufacture an affordable range of sexual health solutions.

Our portfolio comprises medicines for erectile dysfunction and premature ejaculation.

We are one of the trusted ED drug manufacturers and exporters from India.

HIV medicines become less effective when the virus develops mutations relative to the drug.

This leads to the development of drug resistance.

The mutations reduce the HIV response to certain antiretroviral drugs, reducing treatment efficacy.

What is HIV drug resistance?

HIV develops mutations that may reduce its susceptibility to antiretroviral drugs.

The virus can develop resistance with respect to a single drug or to multiple drugs.

Multi-drug resistance may occur when the HIV reduces susceptibility to the same drug class or multiple other drug classes.

Why does a person develop resistance to HIV medication?

Missed doses-

When a person skips or misses the medication.

It reduces the drug concentration and may increase replication or multiplication of HIV.

This favors the development of resistant viral strains.

Pretreatment resistance-

It is a condition in which a person is infected with an HIV strain that is already resistant to certain molecules.

The resistance may be developed due to –

• Previous exposure to the antiretroviral drug.
• Transmission of a drug-resistant virus from another person.

Drug interactions – A few drugs may interact with antiretroviral, reducing their effectiveness.

Absorption-related problems –

Certain gastrointestinal issues or chronic diseases may alter the absorption of antiretroviral drugs.

What are the warning signs that treatment may be failing?

Treatment failure cannot be determined merely by the viral load or the symptoms.

Increased viral load-

Reduced effectiveness of the antiretroviral drugs causes the virus to multiply.

The failure of the treatment cannot be determined by a single spike.

A persistent increase in viral load must be evaluated for treatment failure or drug resistance.

Decreased CD4 count –

CD4 cells are immune cells.

HIV depletes immune cells, lowering their count.

Recurrence of certain symptoms-

Due to a weakened immune system and a rise in viral load, certain symptoms recur.

One may feel fever, fatigue, headache, and swollen lymph glands.

These symptoms do not necessarily indicate HIV treatment failure.

These must be evaluated for the underlying cause.

How to manage HIV drug resistance?

Identifying the mutations-

A genotypic drug-resistance test is run to identify specific mutated strains.

Switch regimens-

A combination of HIV drugs must be changed based on the resistance-test results and the patient’s previous history.

Avoid stopping or missing the drug treatment –

One must not stop the medication on one’s own, as it may speed up resistance or cause treatment failure.

HIV Treatment Medicines (antiretroviral drug combinations):

• Temirazer (Tenofovir Disoproxil Fumarate, Emtricitabine)
• Tudobest-L (Tenofovir Disoproxil Fumarate & Lamivudine)
• Virarazer (Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz)

At Aprazer Healthcare, we manufacture a generic range of medicines.

We are an HIV medicine manufacturer and exporter.

We export HIV drugs to countries in Asia, Africa, and the Americas.

We also offer contract manufacturing services.

• Manufacturing units compliant with GMP
• End-to-end regulatory compliance
• Strict quality assurance and quality control

FAQs

Can HIV resistance be detected through blood tests?

It can be assessed through –

• Genotypic resistance testing
• Phenotypic resistance testing

Do HIV medicines lose effectiveness with time?

HIV medicines do not lose effectiveness on their own.

The efficacy may be reduced due to –

• Sub-optimal adherence
• Drug interactions
• Problems with drug absorption
• HIV drug resistance

How often must one evaluate viral load?

The testing of the viral load is done to assess several factors-

• Treatment response
• Adherence
• Clinical circumstances

Does an increase in viral load always mean resistance to treatment?

No, a temporary increase does not mean resistance.

A persistent elevation in the viral load must be evaluated along with other factors to determine resistance.

Hepatitis therapies may be continued longer depending on the patient’s condition and viral activity.

It may not be necessary for every person with hepatitis B to take medication.

The acute infection may get resolved on its own in healthy individuals, without antivirals.

Antiviral drugs are used in chronic hepatitis B infection.

Does having chronic hepatitis B necessitate antiviral drug treatment?

The need for antiviral drugs depends upon the severity of the infection.

Certain individuals may not need antiviral drug treatment.

The virus may be in an inactive phase, replicating at very low levels.

However, liver function must be monitored regularly to evaluate the patient’s condition.

Acute hepatitis B versus chronic hepatitis B

Acute hepatitis B is an infection that persists for a shorter duration (less than 6 months).

People with strong immunity are able to recover completely on their own and may develop immunity against the virus.

The symptoms may be mild or absent.

It can be managed through various supportive therapies.

Chronic hepatitis B lasts longer than 6 months.

The condition may progress to liver fibrosis and severe inflammation.

The virus transfers its genetic material to the liver cells, and it persists for a long time.

It may require antiviral drug treatment.

How does antiviral treatment help in chronic hepatitis B infection?

These help reduce the viral load.

The antivirals inhibit the enzymes and stop replication of the virus.

They inhibit the progression of the disease.

They help reduce the risk of liver injury.

The mainstay antiviral drugs for chronic hepatitis B-

Entecavir (Entekor) – It is an oral antiviral drug that inhibits enzymes.

It stops viral replication and multiplication.

Tenofovir alafenamide (Tafsure/Tafnext) – It suppresses HBV replication.

It is preferred in when bone or kidney safety are concerned.

Tenofovir disoproxil fumarate (Tudobest) – It is the first-line treatment for certain patients and is used after evaluating other risk factors.

The Hepatitis B medicine manufacturer in India-

Aprazer Healthcare is a pharmaceutical manufacturer specialized in manufacturing hepatitis B medicines.

We have a global supply chain and export network.

Our products are regulatory compliant and focused on safety and quality.

As a third-party manufacturer, we offer manufacturing services and global distribution.

Our manufacturing processes focus on quality assurance and control, preventing cross-contamination.

 

A person can catch a new hepatitis C infection after treatment.

The treatment for hepatitis C does not create immunity against the virus.

How can hepatitis C return?

Hepatitis C may return for several reasons-

New infection– A person can catch a fresh hepatitis C infection, even after prior exposure.

Relapse of the virus – The drug treatment may not be able to completely eradicate the virus.

It occurs when the original virus returns, even after treatment.

Failure of the antiviral therapy – The treatment may not be able to achieve a sustained virological response.

The factors that may contribute include drug resistance, incomplete treatment, drug interactions, and patient condition.

What factors increase the risk of hepatitis C reinfection?

Reinfection may occur due to contamination by infectious blood.

• Using unsterile needles
• Sharing infected needles, razors
• Unsafe sex with an infected person
• Unsterile tattoos and body piercing

Is it always a new infection or the same infection?

Re-infection occurs due to a new infection.

Relapse involves the previous infection. It usually occurs when the virus is not eliminated.

It is the return of the original virus.

What are the symptoms of hepatitis C recurrence?

Many people with active virus infection may not show any symptoms.

However, some symptoms may include-

• Weakness
• Nausea
• Stomach pain
• Vomiting
• Dark colored urine
• Clay-colored stool
• Yellowing of eyes and skin
• Fever and muscle ache

The advanced symptoms that may indicate liver damage-

• Unusual bleeding
• Easy bruising
• Swelling in legs
• Ascites
• Mental confusion

How is hepatitis C treated after recurrence?

The treatment depends upon the type of recurrence.

If it is reinfection or the relapse of the previous infection.

A medical professional needs to evaluate liver health, diseases progression before treatment.

In cases of fresh infection, it is treated with the recommended drugs.

It must be evaluated for any treatment failures during previous infections.

In cases of relapse, a drug regimen is followed based on liver condition, drug resistance, previous medicines, etc.

The commonly used medicines in hepatitis C treatment-

The treatment approach in hepatitis C infection involves inhibiting viral replication.

The drug regimen consists of direct-acting antivirals.

Hepatitis C virus is usually treated with drug combinations.

• Sofosbuvir and velpatasvir
• Ledipasvir and sofosbuvir

How to confirm hepatitis C recurrence?

It must be tested for viral load in the blood.

HCV RNA blood test must be performed to confirm the active infection.

It does not confirm relapse or reinfection.

HCV antibody cannot confirm the recurrence of the infection.

HCV antibody test may remain positive, even after successful treatment.

Which hepatitis medicine manufacturer in India exports medicines globally?

Aprazer Healthcare is a hepatology drug manufacturer.

The drug portfolio spans hepatitis B medicine and hepatitis C medicines.

With world-class infrastructure, we are focused on developing advanced antiviral combinations.

Our flagship products include-

• Sofosbuvir and daclatasvir- Sofokast plus
• Ledipasvir and sofosbuvir- Ledikast
• Sofosbuvir and velpatasvir – Velakast

Liver diseases raise concern due to a rapid increase in fatty liver conditions.

It is not confined to adults or alcoholics; more youngsters are affected by fatty liver.

A fatty liver is often diagnosed at advanced stages.

It does not show visible symptoms at early stages.

Healthy liver versus Fatty liver-

A healthy liver contains minimal fat.

A fatty liver is accompanied by high fat build-ups, involving at least 5% of liver cells.

A healthy liver processes fats/fatty acids and synthesizes triglycerides.

The triglycerides are exported into the bloodstream as VLDL (very low-density lipoproteins).

These are utilized to supply and store energy.

The fatty liver is unable to export or process fat molecules, causing their accumulation in the liver.

How does a healthy liver get converted to a fatty liver?

It is caused by an imbalance between the fat influx and efflux in the liver.

The risk factors include-

1. Diet (excess fat and carbohydrate supply) –

A diet rich in carbohydrates and ultra-processed food causes an increase in fat content and sugars.

2. Obesity –

People with excessive body weight and fat constantly release fatty acids into the bloodstream.

3. Insulin resistance-

It reduces the body’s response to insulin, increasing the release of fatty acids into the bloodstream.

4. Alcohol – It alters fat breakdown in the body. It may lead to over-accumulation.

What may be the early warning signs of fatty liver?

• Persistent fatigue
• Dull pain or feeling of fullness in the upper right side of the abdomen
• General weakness

The signs that may indicate advanced liver disease:

• Jaundice
• Dark urine
• Pale stool
• Easy bleeding
• Swelling of the abdomen or legs
• Confusion or memory issues
• Warm-red palms

How to treat fatty liver?

Fatty liver can be managed or reversed depending on the severity of the condition.

The common measures include:

• Managing weight
• Balancing diet
• Regular exercise
• Managing chronic health conditions

Can ursodeoxycholic acid be helpful in fatty liver disease?

UDCA is not an established treatment for fatty liver.

It is a hydrophilic bile acid.

It is used to treat cholestatic liver disease or biliary conditions.

It alters the composition of the toxic bile pool in the liver and stimulates bile flow.

At Aprazer Healthcare, we manufacture a wide range of gastroenterology medicines.

We are a generic drug manufacturer and exporter, supplying drugs globally.

Focused on hepatobiliary care, our portfolio includes medicines for liver and gastric care.

Our flagship products include –

Udikast – Ursodeoxycholic acid

It is used to dissolve cholesterol gallstones or treat cholestatic liver disease.

Mesalzer – Mesalamine

It is an anti-inflammatory medicine.

It is used to treat mild to moderate IBD and ulcerative colitis.